Pages that link to "Q41194137"

The following pages link to Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. (Q41194137):

Displaying 19 items.

• Etiology and pathogenesis of uterine leiomyomas: a review (Q24815132) (← links)
• The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis (Q26797420) (← links)
• Leiomyomata uteri: hormonal and molecular determinants of growth. (Q36995443) (← links)
• Medical treatment for uterine myomas (Q37133582) (← links)
• Degenerative changes in myometrium simulating diffuse leiomyomatosis after treatment with gonadotrophin releasing hormone analogue (Q37259050) (← links)
• Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. (Q38508715) (← links)
• Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders (Q40398462) (← links)
• Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells (Q40696631) (← links)
• Effects of hormone replacement therapy on postmenopausal uterine myoma (Q42491475) (← links)
• Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue. (Q44203343) (← links)
• Endogenous urinary steroids in premenopausal women with uterine leiomyomas. (Q44708794) (← links)
• Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. (Q45941700) (← links)
• Effects of noncavity-distorting fibroids on endometrial gene expression and function. (Q46019835) (← links)
• Drug treatments for uterine fibroma: rationale (Q46682133) (← links)
• Influence of progesterone and oestrogen on growth and morphology of a transplantable rat uterine smooth muscle tumour (SMT-Y). (Q50854691) (← links)
• Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists. (Q52866191) (← links)
• Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment (Q72534482) (← links)
• Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment (Q73814534) (← links)
• Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT (Q77070806) (← links)